|
AAMP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.54349866221537E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.67665881178891E-12 |
| Normal-vs-Stage2 |
8.164300E-04 |
| Normal-vs-Stage3 |
3.169400E-01 |
| Normal-vs-Stage4 |
5.009400E-01 |
| Stage1-vs-Stage2 |
3.906200E-01 |
| Stage1-vs-Stage3 |
1.616160E-03 |
| Stage1-vs-Stage4 |
1.557430E-01 |
| Stage2-vs-Stage3 |
5.597700E-02 |
| Stage2-vs-Stage4 |
2.349000E-01 |
| Stage3-vs-Stage4 |
8.523400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.15396622549724E-12 |
| Normal-vs-AfricanAmerican |
2.26299999961377E-07 |
| Normal-vs-Asian |
7.777000E-01 |
| Caucasian-vs-AfricanAmerican |
7.966000E-01 |
| Caucasian-vs-Asian |
3.075600E-01 |
| AfricanAmerican-vs-Asian |
1.467580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.30149233004795E-13 |
| Normal-vs-Female |
4.757100E-04 |
| Male-vs-Female |
6.426200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.47920000026502E-07 |
| Normal-vs-Extreme_Weight |
1.94066984704477E-12 |
| Normal-vs-Obese |
2.38409999999689E-05 |
| Normal-vs-Extreme_Obese |
1.838190E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.101400E-01 |
| Normal_Weight-vs-Obese |
3.638800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.806600E-01 |
| Extreme_Weight-vs-Obese |
1.918210E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.939400E-01 |
| Obese-vs-Extreme_Obese |
4.607800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.028000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.29590005393254E-09 |
| Normal-vs-Age(61-80Yrs) |
1.04471986617227E-13 |
| Normal-vs-Age(81-100Yrs) |
4.761600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.098010E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.376600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.609900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.109360E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.908400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.477200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.32587340685131E-14 |
| Normal-VS-Type2 PRCC |
1.53590000051551E-07 |
| Normal-VS-KIRP CIMP |
8.712400E-02 |
| Normal-VS-Unclassified PRCC |
9.63590000000458E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.198020E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.582700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.880200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.22649999995317E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
6.779000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.116900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.71309999963398E-07 |
| Normal-vs-N1 |
9.421000E-01 |
| Normal-vs-N2 |
1.102050E-01 |
| N0-vs-N1 |
9.602400E-03 |
| N0-vs-N2 |
1.73240000000963E-06 |
| N1-vs-N2 |
6.188600E-01 |
|
|
